Long-term memory facilitation in rats by posttraining epinephrine. 1994

D Costa-Miserachs, and I Portell-Cortés, and L Aldavert-Vera, and M Torras-García, and I Morgado-Bernal
Departament de Psicologia de la Salut, Universitat Autònoma de Barcelona, Spain.

Effects of posttraining epinephrine (EPI) on retention of a massed (1 session, 30 trials) 2-way active avoidance task in rats were studied. The rats received an injection (ip) of 0.05 mg/kg EPI, 0.01 mg/kg EPI, or distilled water immediately after the training session. EPI did not improve retention 24 hr after the training session (Experiment 1) but enhanced retention 20 days after the training session (Experiment 2). The group receiving the smaller dose of EPI had better retention than the group receiving the larger dose, indicating dose dependency. The authors suggest that the process of consolidation of massed 2-way active avoidance conditioning is long and elaborative. Posttraining EPI would facilitate this active process of consolidation, improving performance as consolidation goes on. This facilitation needs, at least under certain conditions, more than 24 hr to be expressed as a higher level of performance on the retention test.

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D008297 Male Males
D011939 Mental Recall The process whereby a representation of past experience is elicited. Recall, Mental
D012153 Retention, Psychology The persistence to perform a learned behavior (facts or experiences) after an interval has elapsed in which there has been no performance or practice of the behavior. Psychological Retention,Retention (Psychology),Psychology Retention,Retention, Psychological
D003214 Conditioning, Classical Learning that takes place when a conditioned stimulus is paired with an unconditioned stimulus. Reflex, Conditioned,Classical Conditioning,Classical Conditionings,Conditioned Reflex,Conditionings, Classical
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004837 Epinephrine The active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes systemic VASOCONSTRICTION and gastrointestinal relaxation, stimulates the HEART, and dilates BRONCHI and cerebral vessels. It is used in ASTHMA and CARDIAC FAILURE and to delay absorption of local ANESTHETICS. Adrenaline,4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol,Adrenaline Acid Tartrate,Adrenaline Bitartrate,Adrenaline Hydrochloride,Epifrin,Epinephrine Acetate,Epinephrine Bitartrate,Epinephrine Hydrochloride,Epinephrine Hydrogen Tartrate,Epitrate,Lyophrin,Medihaler-Epi,Acetate, Epinephrine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001143 Arousal Cortical vigilance or readiness of tone, presumed to be in response to sensory stimulation via the reticular activating system. Vigilance, Cortical,Arousals,Cortical Vigilance
D001362 Avoidance Learning A response to a cue that is instrumental in avoiding a noxious experience. Aversion Behavior,Aversion Learning,Aversive Behavior,Aversive Learning,Avoidance Behavior,Aversion Behaviors,Aversive Behaviors,Avoidance Behaviors,Behavior, Aversion,Behavior, Aversive,Behavior, Avoidance,Behaviors, Aversion,Behaviors, Aversive,Behaviors, Avoidance,Learning, Aversion,Learning, Aversive,Learning, Avoidance

Related Publications

D Costa-Miserachs, and I Portell-Cortés, and L Aldavert-Vera, and M Torras-García, and I Morgado-Bernal
October 1988, Behavioral neuroscience,
D Costa-Miserachs, and I Portell-Cortés, and L Aldavert-Vera, and M Torras-García, and I Morgado-Bernal
March 1993, Anesthesia and analgesia,
D Costa-Miserachs, and I Portell-Cortés, and L Aldavert-Vera, and M Torras-García, and I Morgado-Bernal
September 1986, European journal of pharmacology,
D Costa-Miserachs, and I Portell-Cortés, and L Aldavert-Vera, and M Torras-García, and I Morgado-Bernal
August 2001, Journal of applied physiology (Bethesda, Md. : 1985),
D Costa-Miserachs, and I Portell-Cortés, and L Aldavert-Vera, and M Torras-García, and I Morgado-Bernal
April 1996, Behavioral neuroscience,
D Costa-Miserachs, and I Portell-Cortés, and L Aldavert-Vera, and M Torras-García, and I Morgado-Bernal
December 1994, Behavioral neuroscience,
D Costa-Miserachs, and I Portell-Cortés, and L Aldavert-Vera, and M Torras-García, and I Morgado-Bernal
November 1976, Pharmacology, biochemistry, and behavior,
D Costa-Miserachs, and I Portell-Cortés, and L Aldavert-Vera, and M Torras-García, and I Morgado-Bernal
January 1988, Archives internationales de pharmacodynamie et de therapie,
D Costa-Miserachs, and I Portell-Cortés, and L Aldavert-Vera, and M Torras-García, and I Morgado-Bernal
March 2002, Neurobiology of learning and memory,
D Costa-Miserachs, and I Portell-Cortés, and L Aldavert-Vera, and M Torras-García, and I Morgado-Bernal
August 1988, Behavioral neuroscience,
Copied contents to your clipboard!